Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celularity Inc. logo — A next-gen Biotech company creating off-the-shelf cellular m...

Celularity Inc.

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Degenerative Diseases

Founded 2016 United States United States 171 employees Post-IPO Equity Total: $400.00M Biotechnology, Health Care +1

General Information

Company Name Celularity Inc.
Founded Year 2016
Location United States United States
Founders / Decision Makers
Team member Team member Team member
Employees 171
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Celularity Inc.. To contact Celularity Inc., visit celularity.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Celularity Inc. compare?

A PDF of Celularity Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Celularity Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Celularity Inc.

Celularity Inc. is a biotech startup based in Florham Park, N.J. Since its establishment in 2017, the company has been dedicated to revolutionizing cellular medicine by developing off-the-shelf allogeneic placenta-derived cellular therapies at unprecedented scale, quality, and economics. Leveraging the postpartum placenta's therapeutic potential, Celularity utilizes placenta-derived T cells, NK cells, and pluripotent stem cells to address unmet clinical needs in cancer, infectious, and degenerative diseases. The company's innovative approach to cell therapy sets it apart in the biotechnology and healthcare sectors. Celularity's commitment to harnessing the healing properties of the placenta positions it at the forefront of the evolving field of cellular medicine. The recent $30.00M post-IPO equity investment in Celularity on 26 May 2022 underscores the growing interest and confidence in the company's vision and potential. As an investor, it's essential to recognize the disruptive impact Celularity's advancements can make in battling some of the most challenging diseases. For more information, visit celularity.com.

Business keywords: Biotech, Cellular Medicine, Clinical Stage, Cell Therapy, Placenta-Derived Therapies, Allogeneic Therapy, Immunotherapy, T Cells, NK Cells, Pluripotent Stem Cells, Cancer Treatment, Infectious Diseases, Degenerative Diseases, Therapeutic Innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $30.00M -
26 May 2022
Post IPO Equity $80.00M 3
Starr Insurance
Starr Insurance, Sorrento Therapeutics +1
19 Jul 2021
Venture Round $250.00M 7
Heritage Group Celgene Green D Ventures
Heritage Group, Celgene +5
15 Feb 2018
Series A $40.00M -
28 Sep 2017

Celularity Inc. Alternatives & Competitors

View All Alternatives
Celularity Inc. vs
Cell BioEngines, Inc
Cell BioEngines, Inc United States

‘Off-the-Shelf’ Curative Cell Therapies

Pre-Seed
3 employees
Biotechnology, Health and Wellness
Celularity Inc. vs
Fate Therapeutics Inc.
Fate Therapeutics Inc. United States

Transforming the lives of patients with autoimmune diseases and cancer.

227 employees
Biotechnology, Health Care
Celularity Inc. vs
Lineage Cell Therapeutics
Lineage Cell Therapeutics United States

A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

Post-IPO Equity
33 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Celularity Inc.

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Degenerative Diseases
Celularity Inc. was founded in 2016.
Celularity Inc. is headquartered in United States.
Celularity Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Biotech, Cellular Medicine, Clinical Stage and Cell Therapy.
Celularity Inc. has approximately 171 employees.
Celularity Inc. has completed 4 funding rounds, raising a total of $400.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Celularity Inc. include Cell BioEngines, Inc, Fate Therapeutics Inc., Lineage Cell Therapeutics, Tessa Therapeutics Ltd, Minerva Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celularity Inc. and Cell BioEngines, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Celularity Inc., https://bouncewatch.com/company/celularity-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes